Elena Lavezzi

According to an EFPIA - European Federation of Pharmaceutical Industries and Associations study, only 10% of people with diabetes are initiated on insulin at the recommended time. This is a sign of clinical confusion and exemplifies how patients with type 2 diabetes’ needs are not being met. Avalere Health’s experts analyze the roadblocks to care and give six recommendations on how the healthcare industry can support patients in our new whitepaper: https://bit.ly/3yoVcOC #WeAreAvalereHealth #GLP1 #Diabetes

4

📢 Protecting Our Young Ones: Pharmacovigilance in Pediatrics Ensuring the safe use of medications in children is vital to their health and well-being. The unique physiological differences and the frequent need for multiple medications make adverse event reporting especially important for our little patients. Here's why every reaction counts: Dosing Challenges: Improper dosage can lead to overdose in children. Physiological Differences: Underdeveloped organs and varying drug metabolism rates can cause unexpected side effects. Polypharmacy: The use of multiple medicines can lead to dangerous drug interactions. Off-Label Use: Non-standard dosages may lead to complications. Is your child experiencing any adverse reactions like lymphadenopathy, vomiting, dizziness, skin allergies, or seizures? It’s crucial to report even the mildest reaction to ensure safer treatments for all children. 👉 How to Report Adverse Events? Reach out to your nearest ADR Monitoring Center. Submit an ADR reporting form. Call the toll-free number: 1800 180 3024 (Monday to Friday, 9:00 AM to 5:30 PM). Let’s work together to protect the health of our young ones! Be a responsible consumer and report adverse events. 🌟 Issued by the National Coordination Centre - Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare. #Pharmacovigilance #Pediatrics #ChildHealth #SafetyMatters #Healthcare

18

At Sandoz, we believe that driving biosimilar adoption can support more equitable access to high-quality healthcare and improve outcomes for patients across the globe. We’re excited about the opportunity to foster Day 1 access to generics and biosimilars in Europe, improve supply chain resilience and simplify the regulatory framework with the ongoing EU Pharma Review 🌍 This week, Rebecca Guntern, President Region Europe and Country President Switzerland, and Peter Stenico, Global Head of Biosimilars and Country President Austria, spoke at Reuters Events Pharma where they shared their insights on the importance of revising the EU pharmaceutical legislation, regulatory streamlining, and the adoption of smarter procurement processes to increase access to generics and biosimilars in Europe. See below for some key takeaways from Rebecca and Peter 👇 #Biosimilars #Healthcare #REPharma2024 http://bit.ly/43Qc64c

606

2 commenti

🌏 Exploring the Benefits of Conducting Clinical Trials in Asia-Pacific Regions 🏥 Considering conducting clinical trials? Discover why Asia-Pacific regions are the optimal choice! From diverse patient populations to streamlined regulatory processes, Asia-Pacific offers unparalleled advantages for advancing medical research. Learn more in our latest article! #ClinicalTrials #AsiaPacific #MedicalResearch 👉 Contact @Credevo for conducting your clinical trials in the Asia-Pacific region! https://buff.ly/3xCeyzm

2

🌏 Exploring the Benefits of Conducting Clinical Trials in Asia-Pacific Regions 🏥 Considering conducting clinical trials? Discover why Asia-Pacific regions are the optimal choice! From diverse patient populations to streamlined regulatory processes, Asia-Pacific offers unparalleled advantages for advancing medical research. Learn more in our latest article! #ClinicalTrials #AsiaPacific #MedicalResearch 👉 Contact @Credevo for conducting your clinical trials in the Asia-Pacific region! https://buff.ly/3zoiC7i

2

IMEXPHARM PROVIDES COMPREHENSIVE LIVER CARE SOLUTIONS   🆘 According to the Ministry of Health, the rates of liver diseases such as liver cancer, cirrhosis, and complications from cirrhosis are on the rise and increasingly affecting younger people. Notably, many cases occur in individuals under 30 or 35 years old. Health experts recommend that the liver, which performs over 500 different functions in the body, must be protected and strengthened in a timely manner to maintain its optimal condition.   🌐Today, environmental factors, combined with lifestyle habits and frequent exposure to alcohol and unhealthy food, are overburdening the liver. Therefore, to protect liver health, in addition to eliminating harmful habits and unhealthy foods, individuals can supplement with liver support products that help detoxify from within and restore liver function.   💊 In its commitment to public health, Imexpharm has introduced liver protection products certified with GMP standards, offering outstanding benefits:   ✅ Detoxifies, cools the liver, supports bile secretion, and enhances liver function. ✅ Made from natural ingredients such as turmeric extract, pig bile extract, and artichoke extract. ✅ Undergoes rigorous research and careful selection processes. ✅ Proven effective in protecting and strengthening liver health, as validated through studies before the product reaches consumers.   #IMP #Imexpharm #EUGMP #Festale

18

Explore how Sanofi, by transferring their existing Protein A capture step to the Resolute® BioSMB platform, benefited from a 400–500% increase in productivity and a cost reduction of over 80%. Read the case study. https://sar.to/q5vku #SimplifyingProgress #InThisTogether #Chromatography #ResoluteBioSMB

85

Impurities of Tirzepatide : is used together with diet and exercise to help control your blood sugar. https://lnkd.in/dCcgyQEU #simsonpharma #impuritystandards #isotopelabelledcompounds #workingstandards #impuritiesoftirzepatide #researchchemical

16

1 commento

OM Pharma joins EuropaBio, boosting biotech advocacy against global health challenges like AMR, and enhancing Europe's biotech landscape with innovative solutions. 🌍🔬 #BiotechInnovation #PharmaceuticalCompanies #MedTech #RegulatoryAgencies #GlobalHealth #Partnership #MarketAccessToday #MarketAccess

1

Welcome back to our immunization awareness series! In our previous article, we delved into the critical aspects of vaccine safety, debunking common myths and highlighting the stringent testing procedures that guarantee their effectiveness. Today, let's take a closer look at the recommended immunization schedules for individuals across different age groups. THE LIFELONG IMMUNIZATION SCHEDULE Immunization schedules differ between countries as the disease prevalence differs. The schedule below works for most countries, however, it’s important to check with your country’s ministry of health and follow their schedule. 1. Children's Immunization Schedule: Starting at birth with the Hepatitis B vaccine, children undergo a series of immunizations at 2 months, 4 months, 6 months, and throughout childhood. These include protection against diseases like Rotavirus, Diphtheria, Tetanus, Pertussis (DTaP), Measles, Mumps, Rubella (MMR), and more. 2. Adolescents' Immunization Needs: As adolescents transition into their teenage years, additional vaccines such as HPV (Human Papillomavirus), Meningococcal conjugate (MenACWY), and Tetanus, Diphtheria, Pertussis (Tdap) boosters become crucial for their health and well-being. 3. Vaccination for Adults: For adults, staying up-to-date with annual influenza vaccines, tetanus boosters every 10 years, and vaccinations against diseases like Varicella (chickenpox), Hepatitis A and B, and Measles, Mumps, Rubella (MMR) if needed or uncertain about immunity, are recommended to maintain optimal health. CATCH-UP IMMUNIZATION: For those who missed doses or need to catch up on their immunization schedules, healthcare providers can create personalized plans. These catch-up schedules may involve receiving multiple vaccines during a visit or spacing them out as per individual requirements. Stay tuned for upcoming articles. 👉 Found this helpful? Like 👍 and share ⏩ or tag a friend. Follow @OCMM for more insightful updates. ✍🏾 The infographic below depicts the Expanded Program on Immunization #EPI children schedule for Nigeria . #ImmunizationWeek2024 #Day4 #VaccinesWork #PublicHealthMatters #HumanlyPossible #HealthPromotion #HealthEducation #ImmunizationAwareness #ImmunizationSchedule #SafetyMeasure #OCMM

2

Quality control isn't just a process, it's our commitment to your well-being. Discover why rigorous quality checks are crucial in the pharmaceutical industry #PharmaQuality #DrugSafety #HealthcareStandards #Mitrro #MitrroPharma #PharmaMarketplace #B2BPharma #PharmaSolutions #MedicalEquipment #PharmaNetwork #HealthcareInnovation #PharmaIndustry #PharmaBusiness #MedicalSupplies

1

Gain invaluable insights from experts as we navigate the complexities surrounding nitrosamines in pharmaceutical products. Our webinar explores key strategies to address these critical challenges. https://bit.ly/440uDuL #AgilentEMEA #Nitrosamines Ankush Sharma Kylie Wilson Tobias Weimer

19

1 commento

Half way through day 1 of CPHI Milan! Come pop by our stand #16G26 to say hello and see what we can do for you! 👋 🇮🇹 #cphi #cphimilan #pharmaceuticalconsultancy #pharmacovigilance #regulatoryaffairs #medicaldevices #GMDPServices #veterinarypharma #biologicals #cosmetics

15

📢 WHO Pharmacovigilance Newsletter – Key Regulatory Highlights for 2024 🌐 The latest WHO newsletter brings critical updates on the safety and regulatory changes for widely used medications and therapeutic agents. Here are some key points: 📍 Chlorhexidine - New warnings for cutaneous use due to risks of severe corneal injury from accidental ocular exposure, even with protective measures. 📍 CAR T Cell Immunotherapies- Essential regulatory insights on novel safety protocols for chimeric antigen receptor T cell therapies, marking advancements in immune-oncology. 📍 COVID-19 Vaccines (Pfizer and Moderna) - Latest findings on updated safety data to support ongoing vaccination strategies. 📍 GLP-1 Receptor Agonists - Safety monitoring insights for drugs like semaglutide and liraglutide, used in metabolic disorders. This issue also covers Amphotericin B, Bisoprolol, Colistin, Testosterone, and 17-Hydroxyprogesterone Caproate, with significant updates to support safe clinical application. For the complete WHO newsletter, click here: https://lnkd.in/g3mw-x9V #Pharmacovigilance #PatientSafety #WHO #RegulatoryUpdates #Healthcare

5

Last Day of Very Special Incentives - Invest today in our revolution to change the course of inflammation for good and take advantage of these once-in-a-lifetime offers. Learn more here: https://bit.ly/3H47UBu #senjampharma #goodkarmapharma #crowdfunding #wefunder #angelinvestors

5